Call Us Sign-Up/Sign-In
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Peptide Therapeutics: Contract API manufacturing market is estimated to be worth USD 3.2 billion in 2030, predicts Roots Analysis

Peptide Therapeutics

iCrowdNewswire   Jan 5, 2021  3:46 PM ET

Given the growing demand for peptide drugs and the complexities associated with their development and production, relying on the superior technical expertise and experience of CMOs / CDMOs is presently a widely accepted business model

Roots Analysis is pleased to announce the publication of its recent study, titled, “Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030

The “Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030” report features an extensive study of the current market landscape and future opportunities associated with the contract manufacturing of therapeutic peptides. The study also features a detailed analysis of key drivers and trends related to this evolving domain. Amongst other elements, the report includes:

Key companies covered in the report

For more information please click on the following link:

Other Recent Offerings

  1. Peptides and Macrocycle Drug Discovery: Services and Platforms Market, 2020 – 2030
  2. China Biopharmaceutical Contract Manufacturing Market, 2020-2030
  3. Antibody Contract Manufacturing Market, 2020 – 2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415

Contact Information:

Gaurav Chaudhary

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
+1 (415) 800 3415
+44 (122) 391 1091

Keywords:    Checkpoint inhibitors, t cell activation, monoclonal antibodies, ctla4 inhibitor, pd 1, pdl1, Roots Analysis, Research, Biotech, Report, Market Research, Market report, Pharma

Tags:    Extended Distribution, Wire, iCN Internal Distribution, Research Newswire, English